298 related articles for article (PubMed ID: 10749103)
41. Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia.
Pantazopoulos H; Woo TU; Lim MP; Lange N; Berretta S
Arch Gen Psychiatry; 2010 Feb; 67(2):155-66. PubMed ID: 20124115
[TBL] [Abstract][Full Text] [Related]
42. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia.
Stark AK; Uylings HB; Sanz-Arigita E; Pakkenberg B
Am J Psychiatry; 2004 May; 161(5):882-8. PubMed ID: 15121654
[TBL] [Abstract][Full Text] [Related]
43. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain.
Benes FM; Todtenkopf MS; Logiotatos P; Williams M
J Chem Neuroanat; 2000 Dec; 20(3-4):259-69. PubMed ID: 11207424
[TBL] [Abstract][Full Text] [Related]
44. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
[TBL] [Abstract][Full Text] [Related]
45. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
[TBL] [Abstract][Full Text] [Related]
46. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease.
Sheng JG; Griffin WS; Royston MC; Mrak RE
Neuropathol Appl Neurobiol; 1998 Aug; 24(4):278-83. PubMed ID: 9775393
[TBL] [Abstract][Full Text] [Related]
47. Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects.
Crook JM; Akil M; Law BC; Hyde TM; Kleinman JE
Mol Psychiatry; 2002; 7(2):157-64. PubMed ID: 11840308
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression.
Webster MJ; Knable MB; Johnston-Wilson N; Nagata K; Inagaki M; Yolken RH
Brain Behav Immun; 2001 Dec; 15(4):388-400. PubMed ID: 11782105
[TBL] [Abstract][Full Text] [Related]
49. Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease.
Love S; Barber R; Wilcock GK
Brain; 1999 Feb; 122 ( Pt 2)():247-53. PubMed ID: 10071053
[TBL] [Abstract][Full Text] [Related]
50. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease.
Tooyama I; Kimura H; Akiyama H; McGeer PL
Brain Res; 1990 Jul; 523(2):273-80. PubMed ID: 2400911
[TBL] [Abstract][Full Text] [Related]
51. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
Gurevich EV; Joyce JN
Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
[TBL] [Abstract][Full Text] [Related]
52. Reactive microglia in Creutzfeldt-Jakob disease.
Mühleisen H; Gehrmann J; Meyermann R
Neuropathol Appl Neurobiol; 1995 Dec; 21(6):505-17. PubMed ID: 8745240
[TBL] [Abstract][Full Text] [Related]
53. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder.
Toro CT; Hallak JE; Dunham JS; Deakin JF
Neurosci Lett; 2006 Sep; 404(3):276-81. PubMed ID: 16842914
[TBL] [Abstract][Full Text] [Related]
54. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe.
Schultz C; Ghebremedhin E; Del Tredici K; Rüb U; Braak H
Neurobiol Aging; 2004 Mar; 25(3):397-405. PubMed ID: 15123344
[TBL] [Abstract][Full Text] [Related]
55. Hepatocyte growth factor (HGF/SF) in Alzheimer's disease.
Fenton H; Finch PW; Rubin JS; Rosenberg JM; Taylor WG; Kuo-Leblanc V; Rodriguez-Wolf M; Baird A; Schipper HM; Stopa EG
Brain Res; 1998 Jan; 779(1-2):262-70. PubMed ID: 9473690
[TBL] [Abstract][Full Text] [Related]
56. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.
Selemon LD; Rajkowska G; Goldman-Rakic PS
Arch Gen Psychiatry; 1995 Oct; 52(10):805-18; discussion 819-20. PubMed ID: 7575100
[TBL] [Abstract][Full Text] [Related]
57. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'.
Karson CN; Mrak RE; Schluterman KO; Sturner WQ; Sheng JG; Griffin WS
Mol Psychiatry; 1999 Jan; 4(1):39-45. PubMed ID: 10089007
[TBL] [Abstract][Full Text] [Related]
58. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain.
Benes FM; Sorensen I; Vincent SL; Bird ED; Sathi M
Cereb Cortex; 1992; 2(6):503-12. PubMed ID: 1282404
[TBL] [Abstract][Full Text] [Related]
59. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia.
Webster MJ; O'Grady J; Kleinman JE; Weickert CS
Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920
[TBL] [Abstract][Full Text] [Related]
60. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics.
Bachus SE; Hyde TM; Herman MM; Egan MF; Kleinman JE
J Psychiatr Res; 1997; 31(2):233-56. PubMed ID: 9278188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
